MedTrace Logo

Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus

NCT00290979 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2009-08-26

No results posted yet for this study

Summary

* To evaluate non-inferiority in the efficacy of HMR1964 as compared with Insulin lispro in terms of the change in HbA1C from baseline to endpoint.
* To compare the safety of HMR1964 with insulin lispro.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DRUG

insulin glulisine

Sponsors & Collaborators

Principal Investigators

  • Masayoshi KOYAMA · Sanofi

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00290979 on ClinicalTrials.gov